Industry NewsCobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021
Industry NewsCeres Nanosciences receives $243,000 CDC SBIR Phase I award to develop improved viral pathogen surveillance tools
Industry NewsCoronavirus (COVID-19) update: FDA authorizes first point-of-care antibody test for COVID-19
Industry NewsBARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic